Ceptur Therapeutics, Inc. — Form D
Ceptur Therapeutics, Inc. of HILLSBOROUGH, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-09. The offering totals $75.0M, of which $21.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-09
- Form: D
- Accession: 0001810375-22-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $21.5M
- Remaining: $53.5M
- Investors: 9
- Date of first sale: 2021-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436411
Issuer
- Name: Ceptur Therapeutics, Inc.
- CIK: 0001810375
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1 ILENE COURT, BLDG. 8, UNIT 9, HILLSBOROUGH, NJ, 08844
- Phone: 215-330-8399
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Paiman Peter Ghoroghchian | Director | HILLSBOROUGH, NJ |
| Samuel I Gunderson | Director | HILLSBOROUGH, NJ |
| Daniel I Heller | Director | HILLSBOROUGH, NJ |
| Aaron I Kantoff | Director | HILLSBOROUGH, NJ |
| Paiman Peter Ghoroghchian | Executive Officer | HILLSBOROUGH, NJ |
| D. James Ballance | Director | Hillsborough, NJ |
| Rafal Goraczniak | Director | Hillsborough, NJ |
| Cynthia James Davis | Executive Officer | Hillsborough, NJ |
| Samuel Gunderson | Director | Hillsborough, NJ |
| Samuel Gunderson | Executive Officer | Hillsborough, NJ |
| Samuel Gunderson | Promoter | Hillsborough, NJ |
Other filings by this issuer (2)
More